Levitz Michael L 4
4 · Anika Therapeutics, Inc. · Filed Mar 14, 2023
Insider Transaction Report
Form 4
Levitz Michael L
EVP, CFO, Treasurer
Transactions
- Exercise/Conversion
Common Stock
2023-03-10+8,888→ 32,447 total - Exercise/Conversion
Restricted Stock Unit
2023-03-10−8,888→ 17,776 totalExercise: $0.00→ Common Stock (8,888 underlying) - Tax Payment
Common Stock
2023-03-10$26.10/sh−2,609$68,095→ 29,838 total
Footnotes (4)
- [F1]Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 11, 2022.
- [F2]Reflects an aggregate of 2,609 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2023.
- [F3]Reflects the closing price of ANIK common stock on March 10, 2023, the trading day immediately preceding the date on which the vesting of RSUs gave rise to tax withholding obligations.
- [F4]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023.